Effect of anti-sense P-glycoprotein oligomer on P-glycoprotein-positive multidrug-resistant cancers
| Project/Area Number |
05454287
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | MIE UNIVERSITY |
|---|
Principal Investigator |
SAKURAI Minoru Mie University School of Medicine, Professor, 医学部, 教授 (40024707)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
IDO Masaru Mie University School of Medicine, Assistant professor, 医学部, 講師 (90167263)
AZUMA Eiichi Mie University Hospital, Associate professor, 医学部・附属病院, 助教授 (50211008)
|
|---|
| Project Period (FY) |
1993 – 1995
|
| Project Status |
Completed (Fiscal Year 1995)
|
| Budget Amount *help |
¥6,200,000 (Direct Cost: ¥6,200,000)
Fiscal Year 1995: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1994: ¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1993: ¥2,900,000 (Direct Cost: ¥2,900,000)
|
|---|
| Keywords | Multidrug-resistant cancers / P-glycoprotein / Anti-sense oligonucleotide / アンチセンス / P-glycoprotein / Antisense / multidrug resistance |
|---|
| Research Abstract |
Multidrug resistance (mdr) genes encode P-glycoprotein (P-gp), an active transporter that pumps cytotoxic drugs out of cells. Thus, its overexpression is associated with the anticancer drug resistance. Disrupting P-gp/mdr function might, therefore, form the basis of a strategy for overcoming the multidrug resistance of cancer cells. To overcome multidrug resistance in a P-gp-overexpressing P388/ADR murine leukemia cell line, antisense mdrl phosphorothioate-oligodeoxynucleotide (AS-oligomer) was constructed. AS-oligomer inhibited P-glycoprotein expression and mdrl mRNA in vitro in a dose-dependent manner, whereas sense mdrl oligomer (SE-oligomer) had no effect at the doses used. When P388/ADR was treated in vitro with AS-oligomer and doxorubicin (ADR), ADR-resistance was reduced by approximately 2 logs. Furthermore, a single injection of AS-oligomer plus ADR intraperitoneally into B6D2 F1 mice with P388/ADR significantly prolonged mean survival time in a dose-dependent fashion. Again, sense mdrl oligomer had no effect in vivo. No side eddects, either acute or chronic, were found with this treatment during the observation period. These results show that antisense mdrl oligomer could be a useful tool to overcome multidrug resistance.
|
Report
(4 results)
Research Products
(8 results)
